Clinical trial

A Study of Oral N-Acetylcysteine in Children With Autism Spectrum Disorders

NCT00453180 · Indiana University School of Medicine, Other · Completed

Key facts

NCT number NCT00453180
Title A Study of Oral N-Acetylcysteine in Children With Autism Spectrum Disorders
Official title A Pilot Study of Oral N-Acetylcysteine in Children With Autism Spectrum Disorders
Lead sponsor Indiana University School of Medicine, Other
Collaborators National Alliance for Autism Research
Status Completed
Phase Phase 2
Study type Interventional
Conditions Autistic Disorder, Asperger Syndrome, Child Development Disorders, Pervasive
Intervention type Drug
Interventions N-acetylcysteine, Placebo
Enrollment 31
Start date Mar 1, 2007
Primary completion Aug 1, 2009
Completion Nov 1, 2009
First posted Mar 28, 2007
Last update posted Jun 14, 2017
Countries United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies